Family Health Centers of San Diego has launched a three-year effectiveness-implementation hybrid study, the Long COVID and Fatiguing Illness Recovery Program (LC&FIRP), with the aim of improving clinical outcomes and quality of life of those affected by Post-Acute Sequelae of SARS-CoV-2 (PASC), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and other illnesses that cause post-infectious fatigue (OPIFI). This research is funded by the Centers for Disease Control and Prevention (CDC) and is in collaboration with the University of Colorado, the University of New Mexico, the University of Washington, and Ata Health Strategies. The primary objective of the present research is to determine the effectiveness of FHCSD’s LC&FIRP on clinician- and patient-level outcomes. LC&FIRP comprises a teleECHO program focused on multi-specialty case consultation and peer-to-peer sharing of emerging best practices to support the management of complex cases associated with PASC, ME/CFS, and OPIFI. Our secondary objective is to determine the feasibility, acceptability, and sustainability of LC&FIRP. Our findings should provide a fuller understanding of the potential impact of innovative technology-enabled multi-disciplinary team-based care models in low-resource, community-based primary care settings.
Completed